167 related articles for article (PubMed ID: 38507813)
1. Targeting Neuroinflammation by Pharmacologic Downregulation of Inflammatory Pathways Is Neuroprotective in Protein Misfolding Disorders.
Risen SJ; Boland SW; Sharma S; Weisman GM; Shirley PM; Latham AS; Hay AJD; Gilberto VS; Hines AD; Brindley S; Brown JM; McGrath S; Chatterjee A; Nagpal P; Moreno JA
ACS Chem Neurosci; 2024 Apr; 15(7):1533-1547. PubMed ID: 38507813
[TBL] [Abstract][Full Text] [Related]
2. NF-κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective.
Alrouji M; Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Papadakis M; Jabir MS; Saad HM; Batiha GE
J Cell Mol Med; 2023 Jul; 27(13):1775-1789. PubMed ID: 37210624
[TBL] [Abstract][Full Text] [Related]
3. Baohuoside I suppresses the NLRP3 inflammasome activation via targeting GPER to fight against Parkinson's disease.
Gu Y; Hu ZF; Zheng DW; Yang YQ; Dong XL; Chen WF
Phytomedicine; 2024 Apr; 126():155435. PubMed ID: 38394727
[TBL] [Abstract][Full Text] [Related]
4. Prions: generation and spread versus neurotoxicity.
Halliday M; Radford H; Mallucci GR
J Biol Chem; 2014 Jul; 289(29):19862-8. PubMed ID: 24860100
[TBL] [Abstract][Full Text] [Related]
5. Thymopentin (TP-5) prevents lipopolysaccharide-induced neuroinflammation and dopaminergic neuron injury by inhibiting the NF-κB/NLRP3 signaling pathway.
Peng SJ; Feng Y; Li X; Wang XX; Wang Y; Zhou BT; Liu Y; Liu T; Wu YC
Int Immunopharmacol; 2023 Jun; 119():110109. PubMed ID: 37121113
[TBL] [Abstract][Full Text] [Related]
6. Sustained translational repression by eIF2α-P mediates prion neurodegeneration.
Moreno JA; Radford H; Peretti D; Steinert JR; Verity N; Martin MG; Halliday M; Morgan J; Dinsdale D; Ortori CA; Barrett DA; Tsaytler P; Bertolotti A; Willis AE; Bushell M; Mallucci GR
Nature; 2012 May; 485(7399):507-11. PubMed ID: 22622579
[TBL] [Abstract][Full Text] [Related]
7. The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.
Kou L; Chi X; Sun Y; Han C; Wan F; Hu J; Yin S; Wu J; Li Y; Zhou Q; Zou W; Xiong N; Huang J; Xia Y; Wang T
J Neuroinflammation; 2022 Jun; 19(1):133. PubMed ID: 35668454
[TBL] [Abstract][Full Text] [Related]
8. Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease.
Li Y; Xia Y; Yin S; Wan F; Hu J; Kou L; Sun Y; Wu J; Zhou Q; Huang J; Xiong N; Wang T
Front Immunol; 2021; 12():719807. PubMed ID: 34691027
[TBL] [Abstract][Full Text] [Related]
9. Role of NLRP3 inflammasome-mediated neuronal pyroptosis and neuroinflammation in neurodegenerative diseases.
Han YH; Liu XD; Jin MH; Sun HN; Kwon T
Inflamm Res; 2023 Sep; 72(9):1839-1859. PubMed ID: 37725102
[TBL] [Abstract][Full Text] [Related]
10. Essential oil of Acorus tatarinowii Schott inhibits neuroinflammation by suppressing NLRP3 inflammasome activation in 3 × Tg-AD transgenic mice.
Xu Z; Zhou X; Hong X; Wang S; Wei J; Huang J; Ji L; Yang Y; Efferth T; Hong C; Li C
Phytomedicine; 2023 Apr; 112():154695. PubMed ID: 36774844
[TBL] [Abstract][Full Text] [Related]
11. Iron in neurodegenerative disorders of protein misfolding: a case of prion disorders and Parkinson's disease.
Singh N; Haldar S; Tripathi AK; McElwee MK; Horback K; Beserra A
Antioxid Redox Signal; 2014 Jul; 21(3):471-84. PubMed ID: 24512387
[TBL] [Abstract][Full Text] [Related]
12. The role of activity in synaptic degeneration in a protein misfolding disease, prion disease.
Caleo M; Restani L; Vannini E; Siskova Z; Al-Malki H; Morgan R; O'Connor V; Perry VH
PLoS One; 2012; 7(7):e41182. PubMed ID: 22815961
[TBL] [Abstract][Full Text] [Related]
13. Wuzi Yanzong Pill relieves MPTP-induced motor dysfunction and neuron loss by inhibiting NLRP3 inflammasome-mediated neuroinflammation.
Pan T; Xiao Q; Fan HJ; Xu L; Qin SC; Yang LX; Jin XM; Xiao BG; Zhang B; Ma CG; Chai Z
Metab Brain Dis; 2023 Oct; 38(7):2211-2222. PubMed ID: 37470879
[TBL] [Abstract][Full Text] [Related]
14. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
15. Role of Nuclear Factor Kappa B (NF-κB) Signalling in Neurodegenerative Diseases: An Mechanistic Approach.
Singh S; Singh TG
Curr Neuropharmacol; 2020; 18(10):918-935. PubMed ID: 32031074
[TBL] [Abstract][Full Text] [Related]
16. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
17. Harnessing the power of yeast to unravel the molecular basis of neurodegeneration.
Tenreiro S; Munder MC; Alberti S; Outeiro TF
J Neurochem; 2013 Nov; 127(4):438-52. PubMed ID: 23600759
[TBL] [Abstract][Full Text] [Related]
18. Baicalin mitigates cognitive impairment and protects neurons from microglia-mediated neuroinflammation via suppressing NLRP3 inflammasomes and TLR4/NF-κB signaling pathway.
Jin X; Liu MY; Zhang DF; Zhong X; Du K; Qian P; Yao WF; Gao H; Wei MJ
CNS Neurosci Ther; 2019 May; 25(5):575-590. PubMed ID: 30676698
[TBL] [Abstract][Full Text] [Related]
19. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G
Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861
[TBL] [Abstract][Full Text] [Related]
20. CSB6B prevents β-amyloid-associated neuroinflammation and cognitive impairments via inhibiting NF-κB and NLRP3 in microglia cells.
Yan S; Xuan Z; Yang M; Wang C; Tao T; Wang Q; Cui W
Int Immunopharmacol; 2020 Apr; 81():106263. PubMed ID: 32028243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
